Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
Emerita
|
January 1, 1996
The psychic term "ētor": its nature and relation to person in Homer and the Homeric Hymns
S D Sullivan
Social Science & Medicine (1982)
|
December 1, 1994
Firm behavior in the U.S. market for factor VIII: a need for policy?
E Nauenberg, S D Sullivan
Allergy
|
May 1, 2008
An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma
S D Sullivan, F Turk
Pharmacotherapy
|
July 1, 1994
A look at cost-effectiveness
M Gibaldi, S D Sullivan
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 15, 1996
Home care reimbursement for intravenous ganciclovir therapy
E Mozaffari, S D Sullivan
Pharmacotherapy
|
January 1, 1997
Clinical and economic considerations of vaccination against varicella
S A Strassels, S D Sullivan
The Journal of Allergy and Clinical Immunology
|
February 15, 2001
Health economics of asthma and rhinitis. II. Assessing the value of interventions
S D Sullivan, K B Weiss
Medical Care
|
April 1, 1998
On estimating costs for economic evaluation in failure time studies
A P Hallstrom, S D Sullivan
The Journal of the American Board of Family Practice
|
December 28, 1999
Weighing the economic evidence: guidelines for critical assessment of cost-effectiveness analyses
S D Ramsey, S D Sullivan
Pharmacoeconomics
|
June 7, 1993
The economic costs of asthma: a review and conceptual model
K B Weiss, S D Sullivan
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
Emerita
|
January 1, 1996
The psychic term "ētor": its nature and relation to person in Homer and the Homeric Hymns
S D Sullivan
Social Science & Medicine (1982)
|
December 1, 1994
Firm behavior in the U.S. market for factor VIII: a need for policy?
E Nauenberg, S D Sullivan
Allergy
|
May 1, 2008
An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma
S D Sullivan, F Turk
Pharmacotherapy
|
July 1, 1994
A look at cost-effectiveness
M Gibaldi, S D Sullivan
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 15, 1996
Home care reimbursement for intravenous ganciclovir therapy
E Mozaffari, S D Sullivan
Pharmacotherapy
|
January 1, 1997
Clinical and economic considerations of vaccination against varicella
S A Strassels, S D Sullivan
The Journal of Allergy and Clinical Immunology
|
February 15, 2001
Health economics of asthma and rhinitis. II. Assessing the value of interventions
S D Sullivan, K B Weiss
Medical Care
|
April 1, 1998
On estimating costs for economic evaluation in failure time studies
A P Hallstrom, S D Sullivan
The Journal of the American Board of Family Practice
|
December 28, 1999
Weighing the economic evidence: guidelines for critical assessment of cost-effectiveness analyses
S D Ramsey, S D Sullivan
Pharmacoeconomics
|
June 7, 1993
The economic costs of asthma: a review and conceptual model
K B Weiss, S D Sullivan
Page
of 8